Amedeo Smart

Free Medical Literature Service


 

Amedeo

Bladder Cancer

  Free Subscription

05.02.2024

1 Adv Ther
1 Am J Clin Pathol
1 Ann Noninvasive Electrocardiol
1 Anticancer Res
1 Arch Pathol Lab Med
2 Asian J Surg
1 Biochim Biophys Acta Mol Cell Res
1 Biomater Adv
1 BJU Int
2 BMC Cancer
1 BMC Med Imaging
1 BMC Urol
1 Cancer Biomark
1 Carcinogenesis
1 Cell Mol Biol (Noisy-le-grand)
1 Cytotechnology
1 Drug Resist Updat
1 Emerg Med Int
1 Environ Toxicol
1 Eur Heart J Cardiovasc Imaging
1 Eur Urol
2 Eur Urol Focus
2 Eur Urol Oncol
1 Eur Urol Open Sci
3 Front Immunol
1 Front Oncol
1 Front Pharmacol
1 Heliyon
2 Int J Mol Sci
1 Int J Pharm
1 Int J Rheum Dis
1 iScience
1 J Cancer Surviv
1 J Control Release
1 J Endourol
1 J Extracell Vesicles
3 J Gene Med
1 J Mol Diagn
1 J Urol
1 JCO Glob Oncol
1 JNMA J Nepal Med Assoc
1 Nan Fang Yi Ke Da Xue Xue Bao
1 Nat Rev Clin Oncol
1 Nat Rev Urol
1 Nucleosides Nucleotides Nucleic Acids
1 Phys Med Biol
1 PLoS One
4 Sci Rep
1 Toxicol Res (Camb)
2 Urol Oncol
1 Urol Pract
1 Urology
1 Zhonghua Bing Li Xue Za Zhi



    Adv Ther

  1. BLACK PC, Eigl BJ
    The Evolving Role of PD-(L)1 Inhibition in Optimizing Outcomes for High-Risk Non-Muscle-Invasive Bladder Cancer (NMIBC): A Podcast.
    Adv Ther. 2024 Feb 2. doi: 10.1007/s12325-023-02763.
    >> Share


    Am J Clin Pathol

  2. WEI W, Wu D, Zhang Z, Liu J, et al
    Comparison of DNA methylation and cytology tests in urine to detect upper tract urothelial carcinoma: A paired-design diagnostic study.
    Am J Clin Pathol. 2024;161:115-121.
    >> Share


    Ann Noninvasive Electrocardiol

  3. CHEN ZL, Jia KP, Zheng Y, Zhang N, et al
    Electrocardiographic characteristics of bladder cancer patients receiving preoperative chemotherapy combined with immunotherapy.
    Ann Noninvasive Electrocardiol. 2024;29:e13107.
    >> Share


    Anticancer Res

  4. ONER M, Lin E, Chiu KY, Chen MC, et al
    p35/CDK5 Regulates Bladder Cancer Proliferation and Migration and Promotes Higher Tumor Grade and Poor Survival Rate in Patients With Bladder Cancer.
    Anticancer Res. 2024;44:543-553.
    >> Share


    Arch Pathol Lab Med

  5. OLIVER-KRASINSKI JM, Bidot S, Ingram JW, O'Toole KM, et al
    Noninvasive Papillary Urothelial Carcinoma of the Bladder: An Institutional Experience Focusing on Tumors With Borderline Features.
    Arch Pathol Lab Med. 2024;148:223-229.
    >> Share


    Asian J Surg

  6. LV HX, Wang D, Zhou FH
    Definition of the prognosis value of urine extracellular vesicles ZNF540 in bladder cancer based on GEO database.
    Asian J Surg. 2024 Jan 30:S1015-9584(24)00109.
    >> Share

  7. MAO Q, Liu H, Wu J, Cui Y, et al
    Prognostic significance of lncRNA AL354919.2 in bladder cancer.
    Asian J Surg. 2024 Jan 25:S1015-9584(24)00099.
    >> Share


    Biochim Biophys Acta Mol Cell Res

  8. ZHU C, Fang X, Liu X, Jiang C, et al
    Squalene monooxygenase facilitates bladder cancer development in part by regulating PCNA.
    Biochim Biophys Acta Mol Cell Res. 2024;1871:119681.
    >> Share


    Biomater Adv

  9. LIU Y, Qi P, Chen G, Lang Z, et al
    Nanoreactor based on single-atom nanoenzymes promotes ferroptosis for cancer immunotherapy.
    Biomater Adv. 2024;157:213758.
    >> Share


    BJU Int

  10. LU SM, Zhang Y, Dong XT, Wang JL, et al
    Microchip for detection of cell-free DNA in urine to help identify patients with bladder cancer.
    BJU Int. 2024 Jan 30. doi: 10.1111/bju.16271.
    >> Share


    BMC Cancer

  11. PAN DL, Zhang LF, Li XJ, Zhang KP, et al
    Feasibility and safety of laparoscopic radical cystectomy for male octogenarians with muscle-invasive bladder cancer.
    BMC Cancer. 2024;24:159.
    >> Share

  12. VERGHOTE F, Van Praet C, Berquin C, Lumen N, et al
    Radical cystectomy or trimodality therapy for muscle-invasive bladder cancer: a qualitative study exploring patient priorities and counselling needs when making a treatment choice.
    BMC Cancer. 2024;24:160.
    >> Share


    BMC Med Imaging

  13. ZHANG HP, Liang RX, Lin XY, Xue ES, et al
    Application of contrast-enhanced ultrasound in diagnosis and grading of bladder urothelial carcinoma.
    BMC Med Imaging. 2024;24:26.
    >> Share


    BMC Urol

  14. CHEN S, Sun G, Chen X, Salgado T, et al
    Is switching intravesical chemotherapeutic agents beneficial in short-term recurrent high-risk non-muscle-invasive bladder tumors? A 5-year retrospective study.
    BMC Urol. 2024;24:25.
    >> Share


    Cancer Biomark

  15. ZHAO ZY, Cao Y, Wang HL, Liu LY, et al
    A risk model based on lncRNA-miRNA-mRNA gene signature for predicting prognosis of patients with bladder cancer.
    Cancer Biomark. 2024 Jan 8. doi: 10.3233/CBM-230216.
    >> Share


    Carcinogenesis

  16. PAN J, Xie X, Sheng J, Ju C, et al
    Construction and identification of lncRNA/circRNA-coregulated ceRNA networks in gemcitabine-resistant bladder carcinoma.
    Carcinogenesis. 2023;44:847-858.
    >> Share


    Cell Mol Biol (Noisy-le-grand)

  17. SU Y, Chen H, Yao L, Dai H, et al
    The relationship between the expression of lncRNA MALAT1 and clinical features and prognosis in bladder cancer: A meta-analysis.
    Cell Mol Biol (Noisy-le-grand). 2023;69:166-171.
    >> Share


    Cytotechnology

  18. YU J, Ge S
    PRPF19 functions in DNA damage repair and gemcitabine sensitivity via regulating DDB1 in bladder cancer cells.
    Cytotechnology. 2024;76:85-96.
    >> Share


    Drug Resist Updat

  19. LI F, Zhang H, Huang Y, Li D, et al
    Single-cell transcriptome analysis reveals the association between histone lactylation and cisplatin resistance in bladder cancer.
    Drug Resist Updat. 2024;73:101059.
    >> Share


    Emerg Med Int

  20. INTERNATIONAL EM
    Retracted: Preoperative Nutritional Risk Assessment for Predicting Complications after Radical Cystectomy plus Urinary Diversion for Bladder Cancer.
    Emerg Med Int. 2024;2024:9849523.
    >> Share


    Environ Toxicol

  21. LI P, Wang W, Zhu B, Wang Y, et al
    PRDX2 regulates stemness contributing to cisplatin resistance and metastasis in bladder cancer.
    Environ Toxicol. 2024 Jan 31. doi: 10.1002/tox.24153.
    >> Share


    Eur Heart J Cardiovasc Imaging

  22. RICCHETTI G, Grimaldi A, Agricola E, Slavich M, et al
    Cardiac metastasis from urothelial carcinoma: a stealthy precursor.
    Eur Heart J Cardiovasc Imaging. 2024;25:e92.
    >> Share


    Eur Urol

  23. BINHUMAID FS, Goel A, Gordon NS, Abbotts B, et al
    Circulating Tumour Dna Detection By The Urine-Informed Analysis Of Archival Serum Samples From Muscle-Invasive Bladder Cancer Patients.
    Eur Urol. 2024 Jan 31:S0302-2838(24)00017-4. doi: 10.1016/j.eururo.2024.
    >> Share


    Eur Urol Focus

  24. SORIA F, Gontero P
    Reply to Marco Moschini, Francesco Montorsi, Andrea Salonia, Giorgio Gandaglia and Alberto Briganti's Letter to the Editor Re: Francesco Soria, Matteo Rosazza, Simone Livoti, et al. Repeat Transurethral Resection (TUR) + Bacillus Calmette-Guerin (BCG)
    Eur Urol Focus. 2024 Jan 25:S2405-4569(24)00004.
    >> Share

  25. LIN YH, Tsai HY, Juang HH
    Re: Christopher D. Gaffney, Andrew Katims, Neeta D'Souza, Marc A. Bjurlin, Richard S. Matulewicz. Bladder Cancer Carcinogens: Opportunities for Risk Reduction. Eur Urol Focus 2023;9:575-8.
    Eur Urol Focus. 2024 Jan 25:S2405-4569(24)00006.
    >> Share


    Eur Urol Oncol

  26. MARIAPPAN P, Johnston A, Trail M, Hamid S, et al
    Achieving Benchmarks for National Quality Indicators Reduces Recurrence and Progression in Non-muscle-invasive Bladder Cancer.
    Eur Urol Oncol. 2024 Jan 30:S2588-9311(24)00037.
    >> Share

  27. LOBO N, Duan Z, Sood A, Tan WS, et al
    Association of Age with Non-muscle-invasive Bladder Cancer: Unearthing a Biological Basis for Epidemiological Disparities?
    Eur Urol Oncol. 2024 Jan 31:S2588-9311(24)00036.
    >> Share


    Eur Urol Open Sci

  28. NARDELLI C, Aveta A, Pandolfo SD, Tripodi L, et al
    Microbiome Profiling in Bladder Cancer Patients Using the First-morning Urine Sample.
    Eur Urol Open Sci. 2023;59:18-26.
    >> Share


    Front Immunol

  29. YANG H, Ma L, Deng W, Fu B, et al
    Prognostic biomarker DARS2 correlated with immune infiltrates in bladder tumor.
    Front Immunol. 2024;14:1301945.
    >> Share

  30. XU Y, Sun X, Liu G, Li H, et al
    Integration of multi-omics and clinical treatment data reveals bladder cancer therapeutic vulnerability gene combinations and prognostic risks.
    Front Immunol. 2024;14:1301157.
    >> Share

  31. SCHNEIDER AK, Domingos-Pereira S, Cesson V, Polak L, et al
    Type 2 innate lymphoid cells are not involved in mouse bladder tumor development.
    Front Immunol. 2024;14:1335326.
    >> Share


    Front Oncol

  32. MONSHAUGEN I, Luna L, Rhodes J, Kristiansen FIS, et al
    Depletion of the m1A writer TRMT6/TRMT61A reduces proliferation and resistance against cellular stress in bladder cancer.
    Front Oncol. 2024;13:1334112.
    >> Share


    Front Pharmacol

  33. ZHU S, Zhao H
    Sexual dimorphism in bladder cancer: a review of etiology, biology, diagnosis, and outcomes.
    Front Pharmacol. 2024;14:1326627.
    >> Share


    Heliyon

  34. WEI Z, Liu H, Xv Y, Liao F, et al
    Development and validation of a CT-based deep learning radiomics nomogram to predict muscle invasion in bladder cancer.
    Heliyon. 2024;10:e24878.
    >> Share


    Int J Mol Sci

  35. JO A, Joh HM, Bae JH, Kim SJ, et al
    Plasma-Activated Media Produced by a Microwave-Excited Atmospheric Pressure Plasma Jet Is Effective against Cisplatin-Resistant Human Bladder Cancer Cells In Vitro.
    Int J Mol Sci. 2024;25:1249.
    >> Share

  36. LUMKUL L, Jantaree P, Jaisamak K, Wongkummool W, et al
    Combinatorial Gene Expression Profiling of Serum HULC, HOTAIR, and UCA1 lncRNAs to Differentiate Hepatocellular Carcinoma from Liver Diseases: A Systematic Review and Meta-Analysis.
    Int J Mol Sci. 2024;25:1258.
    >> Share


    Int J Pharm

  37. REN Y, Liu T, Li S, Ma X, et al
    An iodine?labelled Antibody-drug conjugate PET probe for noninvasive monitoring of Nectin-4 expression in urothelial carcinoma.
    Int J Pharm. 2024;651:123756.
    >> Share


    Int J Rheum Dis

  38. BANDEIRA M, Dourado E, Lopes F, Tenazinha C, et al
    Reactive arthritis as a rare complication of intravesical bacillus Calmette-Guerin treatment: Report of two cases.
    Int J Rheum Dis. 2024;27:e14862.
    >> Share


    iScience

  39. WANG J, Tan J, Zhang Y, Zhou L, et al
    circCD2AP promotes epithelial mesenchymal transition and stemness in bladder cancer by regulating FOXQ1/USP21 axis.
    iScience. 2023;27:108447.
    >> Share


    J Cancer Surviv

  40. BAHLBURG H, Reicherz A, Reike M, Bach P, et al
    A prospective evaluation of quality of life, psychosocial distress, and functional outcomes two years after radical cystectomy and urinary diversion in 842 German bladder cancer patients.
    J Cancer Surviv. 2024 Jan 30. doi: 10.1007/s11764-024-01535.
    >> Share


    J Control Release

  41. SUN Y, Lu Z, Taylor JA, Au JLS, et al
    Quantitative image analysis of intracellular protein translocation in 3-dimensional tissues for pharmacodynamic studies of immunogenic cell death.
    J Control Release. 2024;365:89-100.
    >> Share


    J Endourol

  42. BAUST JM, Corcoran A, Robilotto A, Katz AE, et al
    Evaluation of a New Cystoscopic Cryocatheter and Method for the In Situ Destruction of Bladder Cancer: Preliminary In vivo Study.
    J Endourol. 2024 Jan 27. doi: 10.1089/end.2023.0635.
    >> Share


    J Extracell Vesicles

  43. DONG L, Feng M, Kuczler MD, Horie K, et al
    Tumour tissue-derived small extracellular vesicles reflect molecular subtypes of bladder cancer.
    J Extracell Vesicles. 2024;13:e12402.
    >> Share


    J Gene Med

  44. SU H, Liu Z, Zhang C, Deng Z, et al
    Exploration of the prognostic effect of costimulatory genes in bladder cancer.
    J Gene Med. 2024;26:e3655.
    >> Share

  45. JIANG S, Yang X, Lin Y, Liu Y, et al
    Unveiling Anoikis-related genes: A breakthrough in the prognosis of bladder cancer.
    J Gene Med. 2024;26:e3651.
    >> Share

  46. WANG CS, Lee YC, Jhan JH, Li WM, et al
    MicroRNA-299-3p inhibits cell proliferation, motility, invasion and angiogenesis via VEGFA in upper tract urothelial carcinoma.
    J Gene Med. 2024;26:e3616.
    >> Share


    J Mol Diagn

  47. ABE M, Hiraki H, Tsuyukubo T, Ono S, et al
    The clinical validity of urinary pellet DNA monitoring for the diagnosis of recurrent bladder cancer.
    J Mol Diagn. 2024 Jan 30:S1525-1578(24)00012.
    >> Share


    J Urol

  48. KAY H, Matulewicz RS, Bjurlin MA
    Clearing the Smoke: Underreporting of Smoking Status in Food and Drug Administration-Approved Bladder Cancer Therapeutic Trials.
    J Urol. 2024 Feb 1:101097JU0000000000003853. doi: 10.1097/JU.0000000000003853.
    >> Share


    JCO Glob Oncol

  49. MANNEH KOPP R, Galanternik F, Schutz FA, Kater F, et al
    Latin American Consensus for the Evaluation and Treatment of Patients With Metastatic/Locally Advanced Urothelial Carcinoma.
    JCO Glob Oncol. 2024;10:e2300244.
    >> Share


    JNMA J Nepal Med Assoc

  50. MISHRA P, Jiongming L, Jianhe L, Kewei F, et al
    Prostate Cancer among Patients Undergoing Radical Cystoprostatectomy for Bladder Cancer in the Department of Urology in a Tertiary Care Centre.
    JNMA J Nepal Med Assoc. 2023;61:782-786.
    >> Share


    Nan Fang Yi Ke Da Xue Xue Bao

  51. YAN Q, Zeng P, Huang S, Tan C, et al
    [RBMX overexpression inhibits proliferation, migration, invasion and glycolysis of human bladder cancer cells by downregulating PKM2].
    Nan Fang Yi Ke Da Xue Xue Bao. 2024;44:9-16.
    >> Share


    Nat Rev Clin Oncol

  52. KLEMM J, Laukhtina E, Shariat SF
    Combination neoadjuvant therapies are paving the way for bladder preservation to become the standard for selected patients.
    Nat Rev Clin Oncol. 2024;21:87-88.
    >> Share


    Nat Rev Urol

  53. GROBET-JEANDIN E, Lenfant L, Pinar U, Parra J, et al
    Management of patients with muscle-invasive bladder cancer with clinical evidence of pelvic lymph node metastases.
    Nat Rev Urol. 2024 Jan 31. doi: 10.1038/s41585-023-00842.
    >> Share


    Nucleosides Nucleotides Nucleic Acids

  54. BOSTANCI E, Kirkik D, Kalkanli Tas S, Uyeturk U, et al
    Genetic insights into bladder cancer: the impact of SIRT1 gene polymorphism.
    Nucleosides Nucleotides Nucleic Acids. 2024.
    >> Share


    Phys Med Biol

  55. YU J, Cai L, Chen C, Zou Y, et al
    A novel predict method for muscular invasion of bladder cancer based on 3D mp-MRI feature fusion.
    Phys Med Biol. 2024 Feb 2. doi: 10.1088/1361-6560.
    >> Share


    PLoS One

  56. KVIKSTAD V, Lillesand M, Gudlaugsson E, Mangrud OM, et al
    Proliferation and immunohistochemistry for p53, CD25 and CK20 in predicting prognosis of non-muscle invasive papillary urothelial carcinomas.
    PLoS One. 2024;19:e0297141.
    >> Share


    Sci Rep

  57. NIE Z, Guo N, Peng Y, Gao Y, et al
    Author Correction: Duality of the SVIL expression in bladder cancer and its correlation with immune infiltration.
    Sci Rep. 2024;14:2369.
    >> Share

  58. IIDA K, Naiki T, Etani T, Nagai T, et al
    Proton pump inhibitors and potassium competitive acid blockers decrease pembrolizumab efficacy in patients with metastatic urothelial carcinoma.
    Sci Rep. 2024;14:2520.
    >> Share

  59. DEMIR R, Koc S, Ozturk DG, Bilir S, et al
    Artificial intelligence assisted patient blood and urine droplet pattern analysis for non-invasive and accurate diagnosis of bladder cancer.
    Sci Rep. 2024;14:2488.
    >> Share

  60. WANG H, Liu J, Lou Y, Liu Y, et al
    Identification and preliminary analysis of hub genes associated with bladder cancer progression by comprehensive bioinformatics analysis.
    Sci Rep. 2024;14:2782.
    >> Share


    Toxicol Res (Camb)

  61. LIU Z, Du D, Zhang S
    Integrated bioinformatics analysis identifies a Ferroptosis-related gene signature as prognosis model and potential therapeutic target of bladder cancer.
    Toxicol Res (Camb). 2024;13:tfae010.
    >> Share


    Urol Oncol

  62. PORRECA A, Di Nicola M, Lucarelli G, Dorin VM, et al
    Time to progression is the main predictor of survival in patients with high-risk nonmuscle invasive bladder cancer: Results from a machine learning-based analysis of a large multi-institutional database.
    Urol Oncol. 2024 Jan 31:S1078-1439(24)00003.
    >> Share

  63. LOTAN Y, Agarwal P, Black P, Dickstein R, et al
    Standardization of the evaluation and surveillance of patients with BCG unresponsive high grade non-muscle invasive bladder cancer clinical trials.
    Urol Oncol. 2024 Feb 1:S1078-1439(24)00020-6. doi: 10.1016/j.urolonc.2024.
    >> Share


    Urol Pract

  64. SEGEL JE, Wong WG, Kaag M, Joshi M, et al
    Relationship Between Availability of Urologists and Primary Care Providers and Stage of Diagnosis for Invasive Urinary Bladder Cancer.
    Urol Pract. 2024 Jan 15:101097UPJ0000000000000503.
    >> Share


    Urology

  65. MORRIS KE, Pappas TN
    Malignancy in the public life: the story of Hubert Humphrey's bladder cancer.
    Urology. 2024 Jan 31:S0090-4295(24)00017-7. doi: 10.1016/j.urology.2023.
    >> Share


    Zhonghua Bing Li Xue Za Zhi

  66. HUANG WQ, Zhang L, Fu S, Shi GZ, et al
    [Mesonephric-like adenocarcinoma of the female urinary bladder associated with endometriosis: report of a case].
    Zhonghua Bing Li Xue Za Zhi. 2024;53:201-203.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016